GSA Capital Partners’s Emergent Biosolutions EBS Stock Holding History

GSA Capital Partners’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$982K	Buy	153,968 +89,348	+138%	+$570K	0.07%	456
2025 Q1	$314K	Buy	64,620 +13,350	+26%	+$64.9K	0.03%	1116
2024 Q4	$490K	Buy	+51,270	New	+$490K	0.04%	905
2023 Q1	–	Sell	-16,793	Closed	-$198K	–	1572
2022 Q4	$198K	Buy	+16,793	New	+$198K	0.02%	1191
2022 Q1	–	Sell	-5,681	Closed	-$247K	–	1512
2021 Q4	$247K	Buy	+5,681	New	+$247K	0.03%	1074
2019 Q2	–	Sell	-21,670	Closed	-$1.1M	–	1511
2019 Q1	$1.1M	Sell	21,670 -14,335	-40%	-$724K	0.11%	253
2018 Q4	$2.13M	Buy	36,005 +7,800	+28%	+$462K	0.25%	45
2018 Q3	$1.86M	Sell	28,205 -42,594	-60%	-$2.8M	0.1%	277
2018 Q2	$3.58M	Sell	70,799 -32,700	-32%	-$1.65M	0.18%	71
2018 Q1	$5.45M	Buy	103,499 +21,000	+25%	+$1.11M	0.29%	18
2017 Q4	$3.83M	Buy	82,499 +68,699	+498%	+$3.19M	0.23%	39
2017 Q3	$558K	Sell	13,800 -14,199	-51%	-$574K	0.04%	898
2017 Q2	$949K	Sell	27,999 -69,700	-71%	-$2.36M	0.06%	588
2017 Q1	$2.84M	Buy	97,699 +2,432	+3%	+$70.6K	0.15%	123
2016 Q4	$3.13M	Sell	95,267 -28,236	-23%	-$927K	0.19%	70
2016 Q3	$3.89M	Buy	123,503 +32,615	+36%	+$1.03M	0.21%	48
2016 Q2	$2.56M	Sell	90,888 -41,676	-31%	-$1.17M	0.14%	146
2016 Q1	$4.82M	Sell	132,564 -10,004	-7%	-$364K	0.31%	9
2015 Q4	$5.7M	Buy	142,568 +17,006	+14%	+$680K	0.28%	22
2015 Q3	$3.58M	Buy	125,562 +6,408	+5%	+$183K	0.18%	79
2015 Q2	$3.93M	Sell	119,154 -10,200	-8%	-$336K	0.15%	97
2015 Q1	$3.72M	Buy	129,354 +26,311	+26%	+$757K	0.15%	100
2014 Q4	$2.81M	Sell	103,043 -3,584	-3%	-$97.6K	0.2%	65
2014 Q3	$2.27M	Buy	106,627 +23,234	+28%	+$495K	0.12%	169
2014 Q2	$1.87M	Buy	83,393 +18,100	+28%	+$407K	0.08%	293
2014 Q1	$1.65M	Buy	65,293 +3,900	+6%	+$98.6K	0.12%	165
2013 Q4	$1.41M	Sell	61,393 -5,094	-8%	-$117K	0.11%	193
2013 Q3	$1.27M	Buy	66,487 +17,493	+36%	+$333K	0.1%	239
2013 Q2	$706K	Buy	+48,994	New	+$706K	0.08%	362